Sign in to see private stats on your profile page — or add photo, interests, videos, mentoring, etc.

    Daniel Adelman, MD

    TitleProfessor
    SchoolUCSF School of Medicine
    DepartmentMedicine
    Address400 Parnassus Avenue
    San Francisco CA 94117
    Phone415-353-2725
    vCardDownload vCard

      Collapse Biography 
      Collapse Education and Training
      University of California DavisM.D.School of Medicine1983

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Murray JA, Kelly CP, Green PH, Marcantonio A, Wu TT, Mäki M, Adelman DC. No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients with Symptomatic Celiac Disease. Gastroenterology. 2016 Nov 15. PMID: 27864127.
        View in: PubMed
      2. Adelman DC, Howard K. Assessing Quality of Life in Patients with Common Variable Immunodeficiency: Why It Matters. J Allergy Clin Immunol Pract. 2016 Nov - Dec; 4(6):1180-1181. PMID: 27836063.
        View in: PubMed
      3. Lähdeaho ML, Kaukinen K, Laurila K, Vuotikka P, Koivurova OP, Kärjä-Lahdensuu T, Marcantonio A, Adelman DC, Mäki M. Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease. Gastroenterology. 2014 Jun; 146(7):1649-58. PMID: 24583059.
        View in: PubMed
      4. Siegel M, Garber ME, Spencer AG, Botwick W, Kumar P, Williams RN, Kozuka K, Shreeniwas R, Pratha V, Adelman DC. Safety, tolerability, and activity of ALV003: results from two phase 1 single, escalating-dose clinical trials. Dig Dis Sci. 2012 Feb; 57(2):440-50. PMID: 21948339.
        View in: PubMed
      5. Krug LM, Crawford J, Ettinger DS, Shapiro GI, Spigel D, Reiman T, Temel JS, Michelson GC, Young DY, Hoch U, Adelman DC. Phase II multicenter trial of voreloxin as second-line therapy in chemotherapy-sensitive or refractory small cell lung cancer. J Thorac Oncol. 2011 Feb; 6(2):384-6. PMID: 21252718.
        View in: PubMed
      6. Advani RH, Hurwitz HI, Gordon MS, Ebbinghaus SW, Mendelson DS, Wakelee HA, Hoch U, Silverman JA, Havrilla NA, Berman CJ, Fox JA, Allen RS, Adelman DC. Voreloxin, a first-in-class anticancer quinolone derivative, in relapsed/refractory solid tumors: a report on two dosing schedules. Clin Cancer Res. 2010 Apr 1; 16(7):2167-75. PMID: 20233886.
        View in: PubMed
      7. Corren J, Shapiro G, Reimann J, Deniz Y, Wong D, Adelman D, Togias A. Allergen skin tests and free IgE levels during reduction and cessation of omalizumab therapy. J Allergy Clin Immunol. 2008 Feb; 121(2):506-11. PMID: 18269927.
        View in: PubMed
      8. Heath EI, Bible K, Martell RE, Adelman DC, Lorusso PM. A phase 1 study of SNS-032 (formerly BMS-387032), a potent inhibitor of cyclin-dependent kinases 2, 7 and 9 administered as a single oral dose and weekly infusion in patients with metastatic refractory solid tumors. Invest New Drugs. 2008 Feb; 26(1):59-65. PMID: 17938863.
        View in: PubMed
      9. Corren J, Diaz-Sanchez D, Saxon A, Deniz Y, Reimann J, Sinclair D, Davancaze T, Adelman D. Effects of omalizumab, a humanized monoclonal anti-IgE antibody, on nasal reactivity to allergen and local IgE synthesis. Ann Allergy Asthma Immunol. 2004 Sep; 93(3):243-8. PMID: 15478383.
        View in: PubMed
      10. Kereiakes DJ, Szyniszewski AM, Wahr D, Herrmann HC, Simon DI, Rogers C, Kramer P, Shear W, Yeung AC, Shunk KA, Chou TM, Popma J, Fitzgerald P, Carroll TE, Forer D, Adelman DC. Phase I drug and light dose-escalation trial of motexafin lutetium and far red light activation (phototherapy) in subjects with coronary artery disease undergoing percutaneous coronary intervention and stent deployment: procedural and long-term results. Circulation. 2003 Sep 16; 108(11):1310-5. PMID: 12939212.
        View in: PubMed
      11. Chou TM, Woodburn KW, Cheong WF, Lacy SA, Sudhir K, Adelman DC, Wahr D. Photodynamic therapy: applications in atherosclerotic vascular disease with motexafin lutetium. Catheter Cardiovasc Interv. 2002 Nov; 57(3):387-94. PMID: 12410519.
        View in: PubMed
      12. Avila PC, Kishiyama JL, Adelman DC. Pharmacological approaches. Clin Allergy Immunol. 2002; 16:469-94. PMID: 11577555.
        View in: PubMed
      13. Chen Z, Woodburn KW, Shi C, Adelman DC, Rogers C, Simon DI. Photodynamic therapy with motexafin lutetium induces redox-sensitive apoptosis of vascular cells. Arterioscler Thromb Vasc Biol. 2001 May; 21(5):759-64. PMID: 11348871.
        View in: PubMed
      14. Margolin K, Gordon MS, Holmgren E, Gaudreault J, Novotny W, Fyfe G, Adelman D, Stalter S, Breed J. Phase Ib trial of intravenous recombinant humanized monoclonal antibody to vascular endothelial growth factor in combination with chemotherapy in patients with advanced cancer: pharmacologic and long-term safety data. J Clin Oncol. 2001 Feb 1; 19(3):851-6. PMID: 11157039.
        View in: PubMed
      15. Gordon MS, Margolin K, Talpaz M, Sledge GW, Holmgren E, Benjamin R, Stalter S, Shak S, Adelman D. Phase I safety and pharmacokinetic study of recombinant human anti-vascular endothelial growth factor in patients with advanced cancer. J Clin Oncol. 2001 Feb 1; 19(3):843-50. PMID: 11157038.
        View in: PubMed
      16. Rockson SG, Kramer P, Razavi M, Szuba A, Filardo S, Fitzgerald P, Cooke JP, Yousuf S, DeVault AR, Renschler MF, Adelman DC. Photoangioplasty for human peripheral atherosclerosis: results of a phase I trial of photodynamic therapy with motexafin lutetium (Antrin). Circulation. 2000 Nov 7; 102(19):2322-4. PMID: 11067782.
        View in: PubMed
      17. Shearer WT, Abramson SL, Adelman DC, Corn B, Cunningham-Rundles C, Kishiyama JL, Richmond W, Shames RS, Sperber K, Stiehm ER, Valacer DJ. Letter to the editor regarding the use of intravenous immunoglobulin (IVIG) in asthma. Clin Immunol. 1999 Nov; 93(2):184-6. PMID: 10527695.
        View in: PubMed
      18. Fahy JV, Cockcroft DW, Boulet LP, Wong HH, Deschesnes F, Davis EE, Ruppel J, Su JQ, Adelman DC. Effect of aerosolized anti-IgE (E25) on airway responses to inhaled allergen in asthmatic subjects. Am J Respir Crit Care Med. 1999 Sep; 160(3):1023-7. PMID: 10471635.
        View in: PubMed
      19. Saini SS, MacGlashan DW, Sterbinsky SA, Togias A, Adelman DC, Lichtenstein LM, Bochner BS. Down-regulation of human basophil IgE and FC epsilon RI alpha surface densities and mediator release by anti-IgE-infusions is reversible in vitro and in vivo. J Immunol. 1999 May 1; 162(9):5624-30. PMID: 10228046.
        View in: PubMed
      20. Kishiyama JL, Valacer D, Cunningham-Rundles C, Sperber K, Richmond GW, Abramson S, Glovsky M, Stiehm R, Stocks J, Rosenberg L, Shames RS, Corn B, Shearer WT, Bacot B, DiMaio M, Tonetta S, Adelman DC. A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma. Clin Immunol. 1999 May; 91(2):126-33. PMID: 10227804.
        View in: PubMed
      21. Shames RS, Heilbron DC, Janson SL, Kishiyama JL, Au DS, Adelman DC. Clinical differences among women with and without self-reported perimenstrual asthma. Ann Allergy Asthma Immunol. 1998 Jul; 81(1):65-72. PMID: 9690575.
        View in: PubMed
      22. Casale TB, Bernstein IL, Busse WW, LaForce CF, Tinkelman DG, Stoltz RR, Dockhorn RJ, Reimann J, Su JQ, Fick RB, Adelman DC. Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis. J Allergy Clin Immunol. 1997 Jul; 100(1):110-21. PMID: 9257795.
        View in: PubMed
      23. MacGlashan DW, Bochner BS, Adelman DC, Jardieu PM, Togias A, McKenzie-White J, Sterbinsky SA, Hamilton RG, Lichtenstein LM. Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J Immunol. 1997 Feb 1; 158(3):1438-45. PMID: 9013989.
        View in: PubMed
      24. Shanafelt MC, Yssel H, Soderberg C, Steinman L, Adelman DC, Peltz G, Lahesmaa R. CD45 isoforms on human CD4+ T-cell subsets. J Allergy Clin Immunol. 1996 Aug; 98(2):433-40. PMID: 8757221.
        View in: PubMed
      25. Adelman DC. Genetic basis of the primary immunodeficiency syndromes. West J Med. 1995 Oct; 163(4):373-4. PMID: 7483602; PMCID: PMC1303141.
      26. Shearer WT, Adelman DC, Huston DP, Engler RJ, Gupta S, Ledford DK, Lopez M, Du Buske LM. Core content outline for clinical and laboratory immunology. AAAI Training Program Directors' Committee. J Allergy Clin Immunol. 1994 Dec; 94(6 Pt 1):933-41. PMID: 7798541.
        View in: PubMed
      27. Kishiyama JL, Adelman DC. The cross-reactivity and immunology of beta-lactam antibiotics. Drug Saf. 1994 Apr; 10(4):318-27. PMID: 8018304.
        View in: PubMed
      28. Hassner A, Lau MS, Goetzl EJ, Adelman DC. Isotype-specific regulation of human lymphocyte production of immunoglobulins by sustained exposure to vasoactive intestinal peptide. J Allergy Clin Immunol. 1993 Dec; 92(6):891-901. PMID: 8258623.
        View in: PubMed
      29. Adelman DC, Yen TY, Cumberland WG, Sidell N, Saxon A. 13-cis retinoic acid enhances in vivo B-lymphocyte differentiation in patients with common variable immunodeficiency. J Allergy Clin Immunol. 1991 Nov; 88(5):705-12. PMID: 1720149.
        View in: PubMed
      30. Hassner A, Adelman DC. Biologic response modifiers in primary immunodeficiency disorders. Ann Intern Med. 1991 Aug 15; 115(4):294-307. PMID: 1854114.
        View in: PubMed
      31. Adelman D. Penicillin allergy. West J Med. 1991 Apr; 154(4):456. PMID: 1877185; PMCID: PMC1002794.
      32. Goetzl EJ, Hassner A, Cheng PP, Robichon A, Adelman DC, Sreedharan SP. Molecular characteristics of the cellular receptor for vasoactive intestinal peptide. Trans Assoc Am Physicians. 1991; 104:54-61. PMID: 1668991.
        View in: PubMed
      33. Goetzl EJ, Cheng PP, Hassner A, Adelman DC, Frick OL, Sreedharan SP. Neuropeptides, mast cells and allergy: novel mechanisms and therapeutic possibilities. Clin Exp Allergy. 1990 Nov; 20 Suppl 4:3-7. PMID: 2282540.
        View in: PubMed
      34. Adelman DC, Matsuda T, Hirano T, Kishimoto T, Saxon A. Elevated serum interleukin-6 associated with a failure in B cell differentiation in common variable immunodeficiency. J Allergy Clin Immunol. 1990 Oct; 86(4 Pt 1):512-21. PMID: 2229813.
        View in: PubMed
      35. Goetzl EJ, Adelman DC, Sreedharan SP. Neuroimmunology. Adv Immunol. 1990; 48:161-90. PMID: 1971989.
        View in: PubMed
      36. Best CL, Walters C, Adelman DC. Fixed cutaneous eruptions to seminal-plasma challenge: a case report. Fertil Steril. 1988 Sep; 50(3):532-4. PMID: 3410107.
        View in: PubMed
      37. Saxon A, Adelman DC, Patel A, Hajdu R, Calandra GB. Imipenem cross-reactivity with penicillin in humans. J Allergy Clin Immunol. 1988 Aug; 82(2):213-7. PMID: 2457043.
        View in: PubMed
      38. Sherr E, Adelman DC, Saxon A, Gilly M, Wall R, Sidell N. Retinoic acid induces the differentiation of B cell hybridomas from patients with common variable immunodeficiency. J Exp Med. 1988 Jul 1; 168(1):55-71. PMID: 3294336; PMCID: PMC2189392.
      39. Adelman DC, Saxon A. Recurrent bacterial infections and cellulitis in a 29-year-old woman with a history of hypogammaglobulinemia. Ann Allergy. 1987 Dec; 59(6):403-4, 456-8. PMID: 3425979.
        View in: PubMed
      40. Saxon A, Beall GN, Rohr AS, Adelman DC. Immediate hypersensitivity reactions to beta-lactam antibiotics. Ann Intern Med. 1987 Aug; 107(2):204-15. PMID: 3300459.
        View in: PubMed
      Daniel's Networks
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Back to TOP